Literature DB >> 15327029

Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains.

P W Tuke1, S Hawke, P D Griffiths, D A Clark.   

Abstract

Multiple sclerosis (MS) is thought to be precipitated by environmental factors, potentially including viruses, in genetically susceptible individuals and recently human herpesvirus 6 (HHV-6) has been associated with the disease. We have analysed post mortem brain for the presence, variant type and quantity of HHV-6 by PCR. A total of 124 samples from seven anatomically defined regions of brain were tested from MS cases and controls. HHV-6 DNA was detected in 41% and 44% of MS case and control samples. The median viral loads were 11 and 9 genome copies/microg DNA in cases and controls respectively and the viral load was not increased in lesions. Except in one instance, the HHV-6 DNA detected was variant B. There was no apparent difference in the distribution of HHV-6 DNA in the brains of MS cases versus controls, nor between normal appearing and lesional tissue in MS cases. Periventricular regions of the brain were more frequently positive for HHV-6 DNA in both MS cases and controls, although this difference was not statistically significant. These studies confirm the neurotropism of HHV-6 but do not demonstrate differences in the distribution, variant type or quantity of HHV-6 in brains from patients with MS versus controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327029     DOI: 10.1191/1352458504ms1057oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

Review 1.  Human herpesvirus 6 infection as a trigger of multiple sclerosis.

Authors:  Konstantine I Voumvourakis; Dimitrios K Kitsos; Sotirios Tsiodras; George Petrikkos; Eleftherios Stamboulis
Journal:  Mayo Clin Proc       Date:  2010-10-06       Impact factor: 7.616

Review 2.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

3.  Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors.

Authors:  John R Crawford; Maria Rita Santi; Robbie Cornelison; Satu-Leena Sallinen; Hannu Haapasalo; Tobey J MacDonald
Journal:  J Neurooncol       Date:  2009-05-08       Impact factor: 4.130

4.  Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells.

Authors:  Guy Mlechkovich; Niza Frenkel
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

5.  Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy.

Authors:  Giuseppe Mameli; Caterina Serra; Vito Astone; Massimiliano Castellazzi; Luciana Poddighe; Enrico Fainardi; Walter Neri; Enrico Granieri; Antonina Dolei
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

6.  Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings.

Authors:  J O Virtanen; J Wohler; K Fenton; D S Reich; S Jacobson
Journal:  Mult Scler       Date:  2013-05-30       Impact factor: 6.312

7.  Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter.

Authors:  Margaret L Opsahl; Peter G E Kennedy
Journal:  Brain       Date:  2005-01-19       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.